Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 19, 2019
Equillium to Host Business Update Call on February 26
LA JOLLA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, will be hosting a ...
February 19, 2019
Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer
AUSTIN, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
February 19, 2019
Spring Bank Pharmaceuticals Appoints Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development
HOPKINTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
February 14, 2019
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2 Study of LPCN 1144 in Biopsy Confirmed NASH Subjects
SALT LAKE CITY, Feb. 14, 2019 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that the U.S. Food & Drug Administration ("FDA") indicated ...
February 14, 2019
Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019
BUFFALO, N.Y., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
February 14, 2019
TYME Reports Encouraging SM-88 Clinical Results without Typical Hormone-Related Side Effects in Phase II Study of Patients with Biomarker Recurrent Prostate Cancer
SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing metabolic-based cancer therapies, announced encouraging preliminary results from ...
February 14, 2019
Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1
REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
February 14, 2019
Outlook Therapeutics Provides Business Update and Reports First Quarter Financial Results for Fiscal 2019
CRANBURY, N.J., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (the “Company”) today reported financial results and business highlights for its first fiscal ...
February 14, 2019
Inspire Medical Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference
MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
February 14, 2019
CorMedix Inc. Announces FDA Meeting Update
BERKELEY HEIGHTS, NJ / ACCESSWIRE / February 14, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
February 14, 2019
Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug ...
February 14, 2019
Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug ...
February 14, 2019
Richard Brudnick to Join InflaRx Board of Directors
JENA, Germany, Feb. 14, 2019 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), an innovative biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced that ...
February 14, 2019
Achaogen Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address ...
February 14, 2019
Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today ...
February 14, 2019
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
DUBLIN, Ireland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage neuroscience company, today reported financial results for the fourth quarter and ...
February 14, 2019
Anchiano Therapeutics Announces Closing of $30.5 Million Initial Public Offering
CAMBRIDGE, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has closed its initial public ...
February 13, 2019
Calabasas Behavioral Health and BrainsWay Host “After the Smoke Clears
CALABASAS, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Calabasas Behavioral Health, a leading mental health service provider in Southern California, announced today that it is ...
February 13, 2019
STRATA Skin Sciences to Participate in the BTIG MedTech, Life Science and Diagnostic Tools Conference
HORSHAM, Pa., Feb. 13, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
February 13, 2019
Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its ...
Page 32 of 158